Welcome to our dedicated page for Innovex International SEC filings (Ticker: INVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating how Innovex International finances next-gen down-hole tools or pinpointing Innovex International insider trading Form 4 transactions is rarely straightforward. Key details on backlog, R&D spend and merger integration costs are buried across hundreds of technical pages.
Stock Titan removes that friction. Every Innovex International quarterly earnings report 10-Q filing, Innovex International annual report 10-K simplified and Innovex International 8-K material events explained arrives here the moment EDGAR posts it. Our AI-powered summaries turn petroleum-engineering jargon into clear language, so understanding Innovex International SEC documents with AI takes minutes, not hours. Need Innovex International Form 4 insider transactions real-time? Get instant alerts the second an executive buys or sells shares.
- Concise AI highlights of segment revenue from drilling, completion and intervention tools
- Searchable text with direct links to cash-flow tables and covenant footnotes
- Downloadable datasets for Innovex International earnings report filing analysis
Whether you’re double-checking Innovex International proxy statement executive compensation, scanning Innovex International executive stock transactions Form 4 before the next rig-count update, or reviewing warranty accruals inside an 8-K, the information is organized for rapid use. Professionals rely on these pages to compare quarter-over-quarter margins, monitor capital allocation and track regulatory risk—without wading through every line themselves. Innovex International SEC filings explained simply: that’s the Stock Titan difference.
Innovex International (INVX) reported strong top-line growth. Q3 2025 revenue was $240,000 thousand versus $151,817 thousand a year ago, driven by gains across products, services, and rentals. Net income was $39,228 thousand, reflecting a $40,918 thousand gain on sale of assets and a $3,342 thousand bargain purchase loss. For the first nine months, revenue reached $704,649 thousand versus $410,116 thousand, with net income of $69,330 thousand.
Cash and restricted cash rose to $163,374 thousand from $73,278 thousand as total liabilities declined to $214,956 thousand and equity increased to $1,038,954 thousand. The company closed acquisitions of Citadel for $69,663 thousand and SCF for $17,721 thousand, expanded intangible assets and goodwill, and completed the sale of its Eldridge facility. A new $200,000 thousand revolving credit facility now matures in 2030, and the term loan was eliminated. INVX authorized a $100,000 thousand share repurchase program and bought 624,531 shares for approximately $9,280 thousand year‑to‑date, with $90,700 thousand remaining authorization.
Innovex International (INVX) furnished an update via Form 8-K, announcing it issued a press release with results for the quarter ended September 30, 2025. The release, included as Exhibit 99.1, contains certain non-GAAP financial measures with reconciliations to the most comparable GAAP metrics.
The information under Items 2.02 and 7.01 is being furnished, not filed, and is not subject to Section 18 liabilities. The Company notes it discloses material information through SEC filings, press releases, public calls, and its investor site at investors.innovex-inc.com.
Innovex International, Inc. (INVX) filed an amended Form 4 reporting an insider stock withholding transaction tied to the release of restricted stock units. Mark Reddout, President of North America and an officer/director, had 4,900 shares withheld to satisfy tax withholding obligations related to RSU vesting. The transaction date was 09/08/2025 and the shares were disposed at $16.82 per share. Following the correction, Reddout beneficially owns 149,412 shares directly. The amendment states the original filing incorrectly reported 3,033 shares withheld and was corrected to 4,900 shares.
The Form 4 is signed by an attorney-in-fact and notes the filing is by one reporting person; no options or derivative transactions are reported.
Innovex International, Inc. (INVX) reporting person Kendal Reed, the company's Chief Financial Officer and director, filed an amended Form 4 to correct a stock withholding report tied to the release of restricted stock units. The filing shows a sale/withholding of 4,900 shares on 09/08/2025 at a price of $16.82 per share to satisfy tax withholding, leaving the reporting person with 206,859 shares beneficially owned. The amendment notes the original filing incorrectly reported 3,033 withheld shares and that the corrected amount is 4,900. The Form 4/A was signed by an attorney-in-fact on behalf of Kendal Reed.
Adam Anderson, Chief Executive Officer and a director of Innovex International, Inc. (INVX), reported a withholding of 13,067 shares to satisfy tax withholding on the release of restricted stock units on 09/08/2025 at a reported price of $16.82 per share. Following the transaction, Anderson beneficially owns 535,271 shares. The filing amends an earlier Form 4 to correct the withheld-share amount, which was originally reported as 12,833 shares; the amendment clarifies the correct withholding is 13,067 shares.
Mark Reddout, President of North America at Innovex International, Inc. (INVX), reported a routine disposition of company stock. On 09/08/2025 he disposed of 3,033 shares of common stock at a reported price of $16.82 per share, and following the transaction he beneficially owned 151,279 shares directly. The filing states the shares were withheld to satisfy tax withholding obligations associated with the release of restricted stock units, indicating vesting-related activity rather than an open-market sale for cash needs. The Form 4 was signed by an attorney-in-fact on 09/10/2025.
Innovex International, Inc. director and CEO Adam Anderson reported a Form 4 disclosing the disposition of 12,833 shares of Common Stock on 09/08/2025 at a price of $16.82 per share. After the transaction, Mr. Anderson beneficially owns 535,505 shares. The filing states the shares were withheld to satisfy tax withholding obligations upon release of restricted stock units, indicating this was not an open-market sale but a tax-related disposition. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Innovex International insider sale from tax-withheld restricted stock units. Innovex CFO Kendal Reed reported a disposition of 3,033 shares of Innovex common stock on 09/08/2025 at a price of $16.82 per share. The filing states the shares were withheld to satisfy tax withholding obligations upon release of restricted stock units. After the withholding, the reporting person beneficially owns 208,726 shares directly. The Form 4 was signed by an attorney-in-fact on 09/10/2025. The filing identifies the reporting person as Chief Financial Officer and provides a Houston, TX mailing address.
FAQ
What is the current stock price of Innovex International (INVX)?
What is the market cap of Innovex International (INVX)?
